4 completed, 2 terminated, 1 active not recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Recurrent Oral Cavity Verrucous Carcinoma: new trials by email Literature Review of Recurrent Oral Cavity Verrucous Carcinoma trials Research Report on Recurrent Oral Cavity Verrucous Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer Laboratory Biomarker Analysis, Photodynamic Therapy, Porfimer Sodium - Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous Carcinoma | Phase 2 | Terminated | Roswell Park Cancer Institute | 3 | 2014-04-01 | 2017-10-11 |
| Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Cisplatin, Laboratory Biomarker Analysis, Pharmacological Study - Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 6 | 2014-03-01 | 2017-05-03 |
| Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer Cetuximab, Laboratory Biomarker Analysis, Lenalidomide - Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2011-02-10 | 2020-03-13 |
| Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy Cetuximab, Laboratory Biomarker Analysis, Temsirolimus - Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 86 | 2010-11-01 | 2017-03-27 |
| Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery Laboratory Biomarker Analysis, Soy Isoflavones, Survey Administration - Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 55 | 2009-07-01 | 2016-10-24 |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Bevacizumab, Carboplatin, Cisplatin - Neck Squamous Cell Carcinoma of Unknown Primary, Recurrent Hypopharyngeal Squamous Cell Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 403 | 2008-08-08 | 2026-10-22 |
| Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer Cediranib Maleate, Laboratory Biomarker Analysis - Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 6 | 2007-02-01 | 2015-05-05 |
Lymphoid Interstitial Pneumonia (7) · Squamous Cell Carcinoma of Head and Neck (7) · Tongue Neoplasms (7) · Salivary Gland Neoplasms (4) · Colonic Neoplasms (1) · Rectal Neoplasms (1)
Carcinoma (7) · Carcinoma, Squamous Cell (7) · Head and Neck Neoplasms (7) · Mouth Diseases (7) · Mouth Neoplasms (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Neoplasms by Site (7) · Neoplasms, Glandular and Epithelial (7) · Stomatognathic Diseases (7) · Tongue Diseases (7) · Salivary Gland Diseases (4) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1)
1,2-diaminocyclohexaneplatinum II citrate (2) · Cetuximab (2) · Cisplatin (2) · Platinum (2) · 1-phenyl-3,3-dimethyltriazene (1) · Bevacizumab (1) · Carboplatin (1) · Dihematoporphyrin Ether (1) · Disulfides (1) · Docetaxel (1) · Fluorouracil (1) · Immunoglobulin G (1) · Lenalidomide (1) · Photochemotherapy (1) · Phototherapy (1)
National Cancer Institute (NCI) (6) · Roswell Park Cancer Institute (1)
United States (6) · Canada (1) · China (1) · Puerto Rico (1) · South Africa (1)
Eric Winquist (1) · Erin M Bertino (1) · Greg Wolf (1) · Hassan Arshad (1) · James Rocco (1) · Tanguy Seiwert (1)
N01CM00032 (1), N01CM00071 (1), N01CM00099 (1), N01CM62201 (1), P30CA006516 (1), P30CA014599 (1), P30CA016056 (1), P30CA016058 (1), P30CA046592 (1), R21CA119591 (1), U01CA076576 (1), U10CA021115 (1), U10CA180820 (1), UM1CA186712 (1)